Edwards Lifesciences (EW) Tops Q1 EPS by 10c; Raises Outlook
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $88.61 --0%
EPS Growth %: +3.2%
Financial Fact:
Interest (income) expense, net: 2.1M
Today's EPS Names:
DGICA, UXIN, TOWN, More
EPS Growth %: +3.2%
Financial Fact:
Interest (income) expense, net: 2.1M
Today's EPS Names:
DGICA, UXIN, TOWN, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q1 EPS of $1.32, $0.10 better than the analyst estimate of $1.22. Revenue for the quarter came in at $993 million versus the consensus estimate of $989.61 million.
GUIDANCE:
Edwards Lifesciences sees FY2019 EPS of $5.10-$5.35, from $5.05 to $5.30 and versus the consensus of $5.21.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- Expro Group Holdings N.V. (XPRO) Reports In-Line Q1 EPS, provides guidance
- Pool Corp. (POOL) Misses Q1 EPS by 1c; beats on guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
